Lexeo Therapeutics, Inc.
Ticker: 1907108
values in millions
| Period | Q3 FY2022 |
|---|---|
| INCOME | |
| Revenue | 0.53 |
| Total Income | 0.53 |
| EXPENSES | |
| Expenditure | 18.01 |
| PROFIT | |
| PBT | -17.06 |
| Net Profit | -17.06 |
| KEY METRICS | |
| OPM % | -100.00% |
| NPM % | -100.00% |
| EPS | -10.38 |
Corporate Events
Board MeetingLXEO
202625Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class III Direc…
SEC Filing ↗ Board MeetingLXEO
202628Apr
Board Meeting
Dr. Laura Sepp-Lorenzino appointed as a new director and mem…
SEC Filing ↗